Literature DB >> 2936863

Induction of IgE synthesis in normal human B cells. Sequential requirements for activation by an alloreactive T cell clone and IgE-potentiating factors.

D Y Leung, M C Young, N Wood, R S Geha.   

Abstract

Two human alloreactive T cell clones were established from a one-way mixed lymphocyte culture involving two nonatopic donors, and were assessed for their capacity to induce IgE synthesis by B cells obtained from the original stimulator. The two alloreactive T cell clones studied induced IgG but not IgE synthesis in normal B cells. However, one of the two clones, clone 2H6, induced IgE synthesis in the presence of supernatants from T cell lines derived from patients with the hyper-IgE syndrome (HIE), and enriched for T cells bearing receptors for IgE. These supernatants by themselves caused no IgE synthesis in nonatopic B cells. The potentiating factors in these supernatants were shown to bind to IgE. Time sequence experiments indicated that interaction of the B cells with the alloreactive clone 2H6 renders them responsive to the action of the IgE-potentiating factors. These results indicate that induction of IgE synthesis in normal B cells involves at least two sequential T cell derived signals. Furthermore, T cell clones are heterogenous in their capacity to provide these signals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936863      PMCID: PMC2188045          DOI: 10.1084/jem.163.3.713

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Dissociation of two signals required for activation of resting B cells.

Authors:  M H Julius; H von Boehmer; C L Sidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

2.  Characteristics and regulatory function of murine con A-induced, cloned T cells obtained from Peyer's patches and spleen: mechanisms regulating isotype-specific immunoglobulin production by Peyer's patch B cells.

Authors:  H Kawanishi; L E Saltzman; W Strober
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

3.  Human IgE synthesis in vitro: a reassessment.

Authors:  H A Sampson; R H Buckley
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

4.  Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia.

Authors:  R S Geha; F S Rosen; E Merler
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

5.  Regulatory role of IgE-binding factors from rat T lymphocytes. I. Mechanism of enhancement of IgE response by IgE-potentiating factor.

Authors:  M Suemura; J Yodoi; M Hirashima; K Ishizaka
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Regulatory role of IgE-binding factors from rat T lymphocytes. III. IgE-specific suppressive factor with IgE-binding activity.

Authors:  M Hirashima; J Yodoi; K Ishizaka
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

7.  Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.

Authors:  A Saxon; C Morrow; R H Stevens
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

8.  Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone.

Authors:  D T Umetsu; D Y Leung; R Siraganian; H H Jabara; R S Geha
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

9.  Stimulation of primary in vitro IgE antibody responses in culture of human peripheral mononuclear cells.

Authors:  M Nonaka; B L Zuraw; C H O'Hair; D H Katz
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Human B cell differentiation. II. Pokeweed mitogen-responsive B cells belong to a surface immunoglobulin D-negative subpopulation.

Authors:  T Kuritani; M D Cooper
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Human IgE biosynthesis in vitro.

Authors:  G Del Prete; E Maggi; S Romagnani; M Ricci
Journal:  Clin Rev Allergy       Date:  1989

2.  Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome.

Authors:  D Vercelli; H H Jabara; C Cunningham-Rundles; J S Abrams; D B Lewis; J Meyer; L C Schneider; D Y Leung; R S Geha
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 3.  Control of IgE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

4.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis.

Authors:  R Paganelli; E Scala; M R Capobianchi; E Fanales-Belasio; G D'Offizi; M Fiorilli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

6.  Functional and phenotypic analysis of human T-cell clones which stimulate IgE production in vitro.

Authors:  D J Quint; E J Bolton; L A McNamee; R Solari; P H Hissey; B R Champion; A R MacKenzie; E D Zanders
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

7.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Y Bonnefoy; H Spits; T Yokota; N Arai; K Arai; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching.

Authors:  H Kikutani; M Suemura; H Owaki; H Nakamura; R Sato; K Yamasaki; E L Barsumian; R R Hardy; T Kishimoto
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.